Literature DB >> 9893318

Use of alternative therapies among breast cancer outpatients compared with the general population.

L VandeCreek1, E Rogers, J Lester.   

Abstract

CONTEXT: Breast cancer is the second largest cause of cancer death among women in the United States. Given the fear associated with its morbidity and mortality, patients might seek a variety of alternative treatments. No careful description of breast cancer patients' interest in or use of these therapies appears to exist.
OBJECTIVE: To create a profile that describes interest in and use of a wide variety of alternative therapies available to breast cancer outpatients; to gather data concerning related issues such as the number of appointments for these therapies, their cost, and reimbursement patterns; and to compare these findings with a published profile of the general public.
DESIGN: An interview gauging patients' interest in and use of alternative treatments followed by 2 questionnaires concerning (1) mental adjustment to the cancer experience and (2) personal growth in response to the encounter with cancer.
SETTING: Suburban breast cancer clinic in a Midwestern university medical center. PARTICIPANTS: 112 female breast cancer outpatients. MAIN OUTCOME MEASURES: Rankings of interest in and use of alternative treatments by the patients interviewed.
RESULTS: The 3 most frequently used alternative therapies were prayer (76%), exercise (38%), and spiritual healing (29%). Comparison with the general public profiles revealed that breast cancer patients more frequently used 17 specific alternative therapies. The largest increases were found in the use of prayer (51% increase), spiritual healing (25% increase), and megavitamins (23% increase). Only chiropractic was used substantially more often among the general population.
CONCLUSION: Breast cancer outpatients involved in conventional treatment are more likely to use a wide range of alternative therapies than is the general public. It is likely that the mortality and morbidity associated with breast cancer motivates this increased use.

Entities:  

Mesh:

Year:  1999        PMID: 9893318

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  18 in total

1.  Relationship with God and the quality of life of prostate cancer survivors.

Authors:  Terry Lynn Gall
Journal:  Qual Life Res       Date:  2004-10       Impact factor: 4.147

2.  Ethnicity and spirituality in breast cancer survivors.

Authors:  Ellen G Levine; Grace Yoo; Caryn Aviv; Cheryl Ewing; Alfred Au
Journal:  J Cancer Surviv       Date:  2007-09       Impact factor: 4.442

3.  Stress and intervention preferences of patients with brain tumors.

Authors:  Stephen T Keir; Ann Bebe Guill; Karen E Carter; Henry S Friedman
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.603

4.  Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice.

Authors:  Mengyuan Du; Xujuan Yang; James A Hartman; Paul S Cooke; Daniel R Doerge; Young H Ju; William G Helferich
Journal:  Carcinogenesis       Date:  2012-01-20       Impact factor: 4.944

5.  Factors Affecting the Tendency of Cancer Patients for Religion and Spirituality: A Questionnaire-Based Study.

Authors:  EdaÖzge Yazgan; Ayten Demir
Journal:  J Relig Health       Date:  2019-06

6.  Complementary and alternative medicine use in breast cancer patients in Europe.

Authors:  Alexander Molassiotis; Julia A Scott; Nora Kearney; Dorit Pud; Miriam Magri; Sarka Selvekerova; Ingrid Bruyns; Paz Fernadez-Ortega; Vassiliki Panteli; Anita Margulies; Gudbjorg Gudmundsdottir; Ljiljana Milovics; Gulten Ozden; Nurgun Platin; Elisabeth Patiraki
Journal:  Support Care Cancer       Date:  2005-09-06       Impact factor: 3.603

7.  Changes in spirituality and quality of life in patients undergoing radiation therapy.

Authors:  Bethany T Samuelson; Erik K Fromme; Charles R Thomas
Journal:  Am J Hosp Palliat Care       Date:  2011-11-21       Impact factor: 2.500

Review 8.  Adverse events associated with complementary and alternative medicine use in ovarian cancer patients.

Authors:  Erin S Sweet; Leanna J Standish; Barbara A Goff; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2013-04-26       Impact factor: 3.279

9.  Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study.

Authors:  Thomas M Habermann; Carrie A Thompson; Betsy R LaPlant; Brent A Bauer; Carol A Janney; Matthew M Clark; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Susan M Geyer; James R Cerhan
Journal:  Am J Hematol       Date:  2009-12       Impact factor: 10.047

10.  Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project.

Authors:  Heather Greenlee; Marilie D Gammon; Page E Abrahamson; Mia M Gaudet; Mary Beth Terry; Dawn L Hershman; Manisha Desai; Susan L Teitelbaum; Alfred I Neugut; Judith S Jacobson
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.